a month ago
WVE
AnalystsBenjamin BurnettBenjamin Burnett's Stock Forecasts
AnalystsBenjamin Burnett
Sectors:
Analyst Ranking
Top 19%
#985 out of 5296 analysts
Average Return
+6.35%
Win Rate
49%52 out of 107
Risk vs Reward
Poor
Good
Benjamin Burnett's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gracell Biotechnologies IncGRCL | +271.38% | $2.76 | $10.25 | 2023-10-19 - 2024-02-21 | Strong Buy |
Revolution Medicines IncRVMD | +189.26% | $33.62 | $97.25 | 2025-04-01 - 2026-03-31 | Strong Buy |
Revolution Medicines IncRVMD | +161.39% | $39.08 | $102.15 | 2025-02-27 - 2026-02-26 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +148.33% | $15.91 | $39.51 | 2025-09-03 - 2026-04-20 | Strong Buy |
Cti Biopharma CorpCTIC | +134.68% | $2.22 | $5.21 | 2021-05-06 - 2022-05-05 | Strong Buy |
Benjamin Burnett Analyst Color
Get additional color on Benjamin Burnett's coverage of popular stocks
a month ago
MNKD
3 months ago
INSM
2 years ago
IRON
Benjamin Burnett's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | 5 | Strong Buy | $14.00 | +138.50% | Maintains | a month ago |
Amphastar Pharmaceuticals IncAMPH | 2 | Hold | $19.00 | -5.43% | Downgrades | a month ago |
Liquidia CorpLQDA | 3 | Strong Buy | $62.00 | -12.96% | Maintains | a month ago |
Ptc Therapeutics IncPTCT | 3 | Strong Buy | $95.00 | +26.43% | Maintains | a month ago |
Insmed IncINSM | 5 | Strong Buy | $160.00 | +63.52% | Maintains | a month ago |
Mannkind CorpMNKD | 4 | Strong Buy | $10.00 | +173.22% | Maintains | a month ago |
United Therapeutics CorpUTHR | 5 | Strong Buy | $738.00 | +35.17% | Upgrades | a month ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $47.00 | +93.02% | Maintains | a month ago |
Alkermes PLCALKS | 5 | Strong Buy | $44.00 | -0.63% | Maintains | a month ago |
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $255.00 | -0.07% | Maintains | a month ago |
Centessa Pharmaceuticals PLCCNTA | 4 | Hold | $42.00 | +5.74% | Downgrades | 2 months ago |
Rapport Therapeutics IncRAPP | 2 | Strong Buy | $46.00 | +19.79% | Maintains | 3 months ago |
Xenon Pharmaceuticals IncXENE | 5 | Strong Buy | $68.00 | +30.52% | Maintains | 3 months ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $20.00 | +97.04% | Maintains | 3 months ago |
Praxis Precision Medicines IncPRAX | 2 | Hold | $305.00 | +14.41% | Maintains | 4 months ago |
Savara IncSVRA | 1 | Strong Buy | $9.00 | +71.10% | Maintains | 6 months ago |
Avadel Pharmaceuticals PLCAVDL | 3 | Hold | $22.50 | +3.97% | Maintains | 7 months ago |
Revolution Medicines IncRVMD | 5 | Strong Buy | $64.00 | N/A | Maintains | a year ago |
Fate Therapeutics IncFATE | 3 | Hold | $3.00 | N/A | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 7 | Hold | $49.00 | N/A | Maintains | a year ago |
Disc Medicine IncIRON | 7 | Strong Buy | $94.00 | N/A | Maintains | a year ago |
Repare Therapeutics IncRPTX | 5 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Arcellx IncACLX | 5 | Strong Buy | $122.00 | N/A | Maintains | 2 years ago |
Beam Therapeutics IncBEAM | 2 | Strong Buy | $69.00 | N/A | Maintains | 2 years ago |
Ideaya Biosciences IncIDYA | 7 | Strong Buy | $68.00 | N/A | Maintains | 2 years ago |
Jasper Therapeutics IncJSPR | 1 | Strong Buy | $86.00 | N/A | Initiates Coverage On | 2 years ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Precigen IncPGEN | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Allogene Therapeutics IncALLO | 4 | Hold | $4.60 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 4 | Hold | $57.50 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 5 | Hold | $2.59 | N/A | Maintains | 2 years ago |
Gracell Biotechnologies IncGRCL | 2 | Hold | $10.25 | N/A | Downgrades | 2 years ago |
Mirati Therapeutics IncMRTX | 6 | Hold | $59.00 | N/A | Downgrades | 3 years ago |
Iovance Biotherapeutics IncIOVA | 9 | Strong Buy | $25.00 | N/A | Reiterates | 3 years ago |
Effector Therapeutics IncEFTR | 4 | Strong Buy | $175.00 | N/A | Upgrades | 3 years ago |
Cti Biopharma CorpCTIC | 2 | Hold | $9.10 | N/A | Downgrades | 3 years ago |
Neurogene IncNGNE | 2 | Hold | $4.50 | N/A | Downgrades | 4 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Genocea Biosciences IncGNCAQ | 1 | Hold | $0.16 | N/A | Downgrades | 4 years ago |
Precision Biosciences IncDTIL | 2 | Strong Buy | $780.00 | N/A | Maintains | 5 years ago |
Nektar TherapeuticsNKTR | 2 | Strong Buy | $360.00 | N/A | Upgrades | 5 years ago |
Sangamo Therapeutics IncSGMO | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Bluebird Bio IncBLUE | 3 | Strong Buy | $1,400.00 | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.